德展健康
(000813)
| 流通市值：84.92亿 | | | 总市值：84.93亿 |
| 流通股本：20.97亿 | | | 总股本：20.97亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,445,190,062.61 | 2,565,530,124.91 | 2,530,699,274.17 | 2,628,102,317.69 |
| 交易性金融资产 | 15,028,022.77 | - | 0 | - |
| 应收票据及应收账款 | 231,850,435.12 | 240,991,197.16 | 284,307,796.15 | 252,251,733.28 |
| 其中：应收票据 | 29,747,888.8 | 23,236,110.07 | 42,080,271.41 | 42,730,577.85 |
| 应收账款 | 202,102,546.32 | 217,755,087.09 | 242,227,524.74 | 209,521,155.43 |
| 预付款项 | 23,543,272.84 | 6,844,259.49 | 7,110,735.94 | 10,279,894.8 |
| 其他应收款合计 | 309,889,433.14 | 336,447,929.34 | 319,453,084.06 | 323,887,686.97 |
| 存货 | 207,189,193.49 | 209,630,292.48 | 197,873,887.61 | 210,732,288.05 |
| 其他流动资产 | 11,614,922.82 | 12,101,531.13 | 11,380,528.02 | 2,776,391.17 |
| 流动资产合计 | 3,244,305,342.79 | 3,371,545,334.51 | 3,350,825,305.95 | 3,428,030,311.96 |
| 非流动资产: | | | | |
| 债权投资 | 20,000,000 | - | 0 | - |
| 长期股权投资 | 482,293,551.9 | 488,586,757.78 | 492,563,362.83 | 424,531,969.24 |
| 其他权益工具投资 | 71,725,600 | 71,725,600 | 71,725,600 | 100,000,000 |
| 固定资产 | 709,626,379.56 | 734,434,111.62 | 742,664,051.03 | 728,805,431.74 |
| 在建工程 | 98,366,365.89 | 60,894,563.64 | 43,852,997.45 | 46,705,978.26 |
| 使用权资产 | 27,748,383.01 | 21,730,079.9 | 16,702,205.42 | 17,265,880.81 |
| 无形资产 | 156,493,890.42 | 161,535,849.96 | 166,540,473.75 | 170,459,478.47 |
| 开发支出 | 15,565,262.64 | 12,312,923.95 | 9,833,653.31 | - |
| 商誉 | 289,714,984.06 | 289,714,984.06 | 289,714,984.06 | 289,714,984.06 |
| 长期待摊费用 | 89,663,457.49 | 78,534,302.16 | 77,689,807.46 | 16,585,905.44 |
| 递延所得税资产 | 30,237,144.37 | 31,244,489.32 | 31,202,280.77 | 22,282,509.32 |
| 其他非流动资产 | 37,722,627.03 | 33,618,871.9 | 26,518,898.46 | 55,417,422.76 |
| 非流动资产合计 | 2,029,157,646.37 | 1,984,332,534.29 | 1,969,008,314.54 | 1,871,769,560.1 |
| 资产总计 | 5,273,462,989.16 | 5,355,877,868.8 | 5,319,833,620.49 | 5,299,799,872.06 |
| 流动负债: | | | | |
| 短期借款 | 143,333.35 | 266,190.49 | 389,047.63 | 470,952.39 |
| 应付票据及应付账款 | 17,696,168.84 | 16,013,856.39 | 15,945,952.55 | 11,695,763.95 |
| 应付账款 | 17,696,168.84 | 16,013,856.39 | 15,945,952.55 | 11,695,763.95 |
| 合同负债 | 197,102.24 | 216,280.65 | 204,899.41 | 199,916.81 |
| 应付职工薪酬 | 6,551,563.02 | 12,901,388.51 | 10,329,997.86 | 10,491,632.58 |
| 应交税费 | 5,227,832.72 | 13,294,785.67 | 11,233,671.17 | 4,205,605.74 |
| 其他应付款合计 | 57,781,314.56 | 85,691,020.99 | 68,292,401.94 | 63,217,834.46 |
| 应付股利 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
| 一年内到期的非流动负债 | 5,658,051.5 | 3,471,978.08 | 3,474,143.46 | 1,116,357.97 |
| 其他流动负债 | 540.02 | 4,820.6 | 3,704.09 | 5,030.81 |
| 流动负债合计 | 93,255,906.25 | 131,860,321.38 | 109,873,818.11 | 91,403,094.71 |
| 非流动负债: | | | | |
| 长期借款 | 114,800,000 | 40,000,000 | 0 | - |
| 租赁负债 | 23,621,806.58 | 18,877,026.32 | 14,264,750.05 | 16,132,693.98 |
| 长期应付款 | 5,032,000 | 5,032,000 | 5,032,000 | 5,000,000 |
| 递延收益 | 5,312,034.55 | 5,701,377.19 | 6,090,719.83 | 6,480,062.47 |
| 递延所得税负债 | 20,080,967.82 | 18,733,790.6 | 19,622,766.37 | 20,583,907.87 |
| 非流动负债合计 | 168,846,808.95 | 88,344,194.11 | 45,010,236.25 | 48,196,664.32 |
| 负债合计 | 262,102,715.2 | 220,204,515.49 | 154,884,054.36 | 139,599,759.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 869,084,133 | 869,084,133 | 869,084,133 | 869,084,133 |
| 资本公积 | 462,068,139.98 | 455,232,104.66 | 455,232,104.66 | 405,940,303.29 |
| 减:库存股 | 180,391,021.92 | 73,275,022.91 | 73,275,022.91 | 59,949,480.2 |
| 其他综合收益 | -30,399,400 | -30,399,400 | -30,399,400 | -2,125,000 |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 23,813,477.29 | 23,813,477.29 | 23,813,477.29 | 23,813,477.29 |
| 未分配利润 | 3,870,641,697.38 | 3,891,453,309.19 | 3,913,568,180.55 | 3,942,070,697.28 |
| 归属于母公司股东权益合计 | 5,014,817,025.73 | 5,135,908,601.23 | 5,158,023,472.59 | 5,178,834,130.66 |
| 少数股东权益 | -3,456,751.77 | -235,247.92 | 6,926,093.54 | -18,634,017.63 |
| 股东权益合计 | 5,011,360,273.96 | 5,135,673,353.31 | 5,164,949,566.13 | 5,160,200,113.03 |
| 负债和股东权益合计 | 5,273,462,989.16 | 5,355,877,868.8 | 5,319,833,620.49 | 5,299,799,872.06 |
| 公告日期 | 2025-08-23 | 2025-04-29 | 2025-04-29 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |